Blicinto is proven with blood type cancer and as widely known, SOLUD TUMOURS is a whole new parameter in terms of effective immunotherapy treatments and first to market by whoever/whenever it may happen will be the significant beneficiaries.
We also have Car T therapy in combo with CF33 which ignites my excitement!
Anyway it's a waiting game.....
Ann: Imugene Phase 1 onCARlytics CD19 virus clinical trial opens, page-59
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.3¢ | $537.6K | 10.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 207796 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 1452903 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |